Chad J. Kolean
2022
In 2022, Chad J. Kolean earned a total compensation of $461.6K as Chief Financial Officer at Cellectar Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $113,146 |
|---|---|
| Option Awards | $58,080 |
| Salary | $290,417 |
| Total | $461,643 |
Kolean received $290.4K in salary, accounting for 63% of the total pay in 2022.
Kolean also received $113.1K in non-equity incentive plan and $58.1K in option awards.
Rankings
In 2022, Chad J. Kolean's compensation ranked 4,486th out of 5,760 executives tracked by ExecPay. In other words, Kolean earned more than 22.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,486 out of 5,760 | 22nd |
Division Manufacturing | 2,522 out of 3,136 | 20th |
Major group Chemicals And Allied Products | 1,211 out of 1,422 | 15th |
Industry group Drugs | 1,138 out of 1,323 | 14th |
Industry Pharmaceutical Preparations | 831 out of 969 | 14th |
Source: SEC filing on April 26, 2024.
Kolean's colleagues
We found two more compensation records of executives who worked with Chad J. Kolean at Cellectar Biosciences in 2022.